BILLERICA, Mass., Jan. 24, 2017 /PRNewswire/ -- Bruker today
announced that it has acquired Hysitron, Inc., a technology leader
in the development, manufacture, and sale of nanomechanical test
instrumentation. The acquisition adds Hysitron's innovative
nanomechanical testing instruments to Bruker's existing portfolio
of atomic force microscopes (AFMs), surface profilometers, and
tribology and mechanical testing systems, significantly enhancing
Bruker's leadership position in nanomaterials research markets.
Hysitron's 2016 revenues were approximately $20 million. Financial details of the transaction
were not disclosed.
Headquartered in Eden Prairie,
Minnesota, privately-held Hysitron® has pioneered
solutions to measure mechanical properties of materials at the
nanoscale since 1992. Its industry-leading nanoindentation products
are used by premier academic and industrial researchers and
engineers in materials science, the life sciences, and
semiconductor applications. In addition to nanoindentation and
microindentation, Hysitron's instrument capabilities include
tribology, modulus mapping, dynamic mechanical analysis, and
in-situ SEM (scanning electron) and TEM (transmission electron)
nanomechanical testing.
"Hysitron has been recognized as the global market and
technology leader in the field of nanomechanical property
measurements for quite some time," said Mark R. Munch, Ph.D., President of the Bruker
NANO Group. "As a leader in atomic force microscopy
instrumentation, we plan to realize a number of valuable
application synergies by adding Hysitron's instruments to our
Bruker NANO Group nanoscale surface and materials characterization
product portfolio. In addition, Hysitron's products are quite
complementary to our macroscale mechanical and tribology test
instruments, providing the most complete range of testing
capabilities to the market."
"We have built a strong reputation at Hysitron for truly
top-level instrumentation that pushes the limits of nanoindenting
technology, but have been looking to leverage the strengths of a
larger global organization to help bring these capabilities to
their full potential," added Thomas
Wyrobek, CEO and Co-Founder of Hysitron, Inc. "With Bruker's
great commitment to research and their long history of academic
collaboration, we are excited about the ways they can provide the
global infrastructure and processes that we have always wanted,
while maintaining intense focus on developing the best possible
solutions to enable our customers' success."
Forward-Looking Statements
This press release includes
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements may be identified by the use of words such as
"anticipate," "believe," "expect," "will," "may," "estimate,"
"plan," "outlook," and "project" and other similar expressions that
predict or indicate future events or trends or that are not
statements of historical matters. Such forward-looking statements
reflect the views of management at the time such statements are
made and are subject to a number of risks, uncertainties,
estimates, and assumptions that may cause actual results to differ
materially from current expectations. Although we believe the
assumptions upon which these forward-looking statements are based
are reasonable, any of these assumptions could prove to be
inaccurate and the forward-looking statements based on these
assumptions could be incorrect. Our actual future performance may
differ materially from such expectations as a result of important
risk factors, which include, in addition to those identified in our
Annual Report on Form 10-K for the year ended December 31, 2015 and our other subsequent
filings with the Securities and Exchange Commission, risks and
uncertainties associated with our ability to finalize and close,
and then manage and integrate the acquisition of Hysitron, Inc.
These risks and uncertainties could cause actual results to differ
materially from those stated or implied in these forward-looking
statements. We expressly disclaim any obligation to update or
revise these forward-looking statements, except as required by law
or regulation.
About Hysitron, Inc.
Hysitron is the world leader in the development and
commercialization of nanomechanical test instruments and has
designed, manufactured, and serviced cutting-edge technology for
the scientific community since 1992. As the pioneer of in-situ
imaging with nanomechanical property measurement capabilities,
Hysitron has grown with the nanotechnology market for over two
decades.
About Bruker Corporation (NASDAQ: BRKR)
For more than 50 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve
the quality of human life. Bruker's high-performance scientific
research instruments and high-value analytical solutions enable
scientists to explore life and materials at molecular, cellular and
microscopic levels.
In close cooperation with our customers, Bruker is enabling
innovation, productivity and customer success in life science
molecular research, in applied and pharma applications, in
microscopy, nano-analysis and industrial applications, as well as
in cell biology, preclinical imaging, clinical research,
microbiology and molecular diagnostics. For more information,
please visit www.bruker.com.
Investor Contact:
Miroslava
Minkova
Bruker Head of Investor Relations
T: +1 (978) 663-3660 x1479
E: miroslava.minkova@bruker.com
Media Contact:
Stephen
Hopkins
Bruker Nano Surfaces MarCom Supervisor
T: +1 (520) 741-1044 x1022
E: steve.hopkins@bruker.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/bruker-announces-acquisition-of-nanoindenting-leader-hysitron-300395228.html
SOURCE Bruker Corporation